Silvercrest Asset Management’s Genprex GNPX Stock Holding History

Silvercrest Asset Management’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$12.9K	–	896
2023 Q4	$12.9K	Hold	1	–	–	﹤0.01%	834
2023 Q3	$22.1K	Hold	1	–	–	﹤0.01%	822
2023 Q2	$53.1K	Hold	1	–	–	﹤0.01%	809
2023 Q1	$51K	Hold	1	–	–	﹤0.01%	780
2022 Q4	$81.2K	Hold	1	–	–	﹤0.01%	769
2022 Q3	$79K	Hold	1	–	–	﹤0.01%	772
2022 Q2	$78K	Hold	1	–	–	﹤0.01%	780
2022 Q1	$127K	Hold	1	–	–	﹤0.01%	823
2021 Q4	$73K	Hold	1	–	–	﹤0.01%	814
2021 Q3	$150K	Hold	1	–	–	﹤0.01%	823
2021 Q2	$188K	Hold	1	–	–	﹤0.01%	810
2021 Q1	$155K	Buy	+1	New	+$220K	﹤0.01%	816
2020 Q4	–	Hold	0	–	–	–	786

Other funds holding GNPX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Silvercrest Asset Management's GNPX Position: Q1 2024 in Review

Silvercrest Asset Management sold out of Genprex (GNPX) in Q1 2024, closing a stake of 1 share — an estimated $12.9K sold.

Silvercrest Asset Management first reported a position in GNPX in Q1 2021 and held it in 12 quarters. The position peaked at $188K in Q2 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

Silvercrest Asset Management reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
Silvercrest Asset Management sold 1 Genprex share in Q1 2024, an estimated $12.9K.
Silvercrest Asset Management first reported a position in Genprex in Q1 2021 and held it in 12 quarters.
Silvercrest Asset Management's Genprex position peaked at $188K in Q2 2021.
8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Silvercrest Asset Management's 13F filing for Q1 2024, filed 15 May 2024.